相关实验视频
Updated: May 27, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
开始Omnipod DASH®与管式胰岛素治疗的时间:一项时间和运动研究
Charlotte A Gordon1, Meike Graf2, Colin D Hopley3
1Northumbria University Coach Lane Campus (East), Newcastle upon Tyne, NE7 7XA, UK.
概括
启动无管胰岛素疗法 (IPT) 的时间比管式要少13分钟,为医疗保健提供者提供了显著的效率提升. 这种节省时间最明显的是,当患者从面对面的环境中从每天多次注射 (MDI) 转换时.
科学领域:
- 内分泌学 在内分泌学.
- 医疗器械 医疗器械
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对标准胰岛素疗法 (IPT) 启动过程和按类型的变化了解有限.
- 进行了一项时间和运动研究,以比较无管胰岛素和管式胰岛素的启动时间.
研究的目的:
- 评估和比较启动无管胰岛素治疗 (IPT) 与传统管式所需的时间.
- 在IPT启动过程中识别潜在的效率.
主要方法:
- 一项涉及糖尿病专家护士自我记录启动时间的时间和运动研究.
- 通过基于网络的工具收集的数据,涉及德国和英国的276个启动 (112个无管,164个管道) 的数据.
- 包括有或没有先前IPT经验的成年人,面对面和远程启动.
主要成果:
- 与无管IPT (131分钟) 相比,无管IPT的启动时间平均短13分钟 (118分钟).
- 在从多次每日注射 (MDI) 过渡到面对面设置的患者中观察到显著的时间节省.
- 护士报告说,尽管时间缩短,但无管IPT启动同样有效.
结论:
- 与无管系统相比,无管胰岛素治疗 (IPT) 的启动提供了显著的时间缩短.
- 实施这些节约时间可以提高效率并减少服务中的工作负载.
- 建议在IPT和自动胰岛素输送 (AID) 启动时进行进一步的时间和运动研究.
更多相关视频
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
139
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
139
Insulin Formulations: Types and Delivery
160
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
160
One-Compartment Open Model for IV Bolus Administration: General Considerations
150
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
150
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
178
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
178
Two-Compartment Open Model: IV Bolus Administration
363
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
363

